We are live on
!
Find out more
HighTower Advisors Portfolio holdings
AUM
$94.2B
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
+0.53%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$94.2B
AUM Growth
+$2.78B
(+3%)
Cap. Flow
+$3.88B
Cap. Flow
% of AUM
4.12%
Top 10 Holdings %
Top 10 Hldgs %
19.22%
Holding
3,988
New
344
Increased
1,983
Reduced
1,302
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$541M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$338M |
| 4 |
Apple
AAPL
|
+$199M |
| 5 |
NVIDIA
NVDA
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$129M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$125M |
| 3 |
VanEck High Yield Muni ETF
HYD
|
+$94.7M |
| 4 |
Teradyne
TER
|
+$67.3M |
| 5 |
Oracle
ORCL
|
+$56.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.05% |
| 2 | Financials | 8.61% |
| 3 | Healthcare | 6.66% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Industrials | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CALL
Global X Dow 30 Covered Call ETF
DJIA
$182M
| $25.3K | ﹤0.01% |
120,100
+20,000
| +20% | +$440K |
|
3752
Fractyl Health
GUTS
$123M
| $23.6K | ﹤0.01% |
51,442
| – | – |
|
3753
Alector
ALEC
$164M
| $23.1K | ﹤0.01% |
10,760
+749
| +7% | +$1.5K |
|
3754
Gossamer Bio
GOSS
$66.5M
| $21.6K | ﹤0.01% |
65,630
-864
| -1% | -$1.36K |
|
|
OSTX
3755
OS Therapies Inc
OSTX
$67.7M
| $21.4K | ﹤0.01% |
+15,200
| New | +$21.6K |
|
|
BRNS
3756
Barinthus Biotherapeutics
BRNS
$24.6M
| $21.3K | ﹤0.01% |
37,450
| – | – |
|
3757
iQIYI
IQ
$1.18B
| $20.9K | ﹤0.01% |
15,501
| – | – |
|
3758
Inovio Pharmaceuticals
INO
$79.8M
| $20.7K | ﹤0.01% |
11,899
+750
| +7% | +$1.24K |
|
3759
RenovoRx
RNXT
$39M
| $20.2K | ﹤0.01% |
20,000
| – | – |
|
3760
Calidi Biotherapeutics
CLDI
$1.93M
| $19.9K | ﹤0.01% |
83,523
| – | – |
|
|
EU
3761
enCore Energy
EU
$221M
| $18.9K | ﹤0.01% |
+10,480
| New | +$26.8K |
|
3762
FingerMotion
FNGR
$16.2M
| $18.7K | ﹤0.01% |
18,805
| – | – |
|
3763
DocGo
DCGO
$58.9M
| $18.5K | ﹤0.01% |
29,446
+8,357
| +40% | +$6.29K |
|
3764
Cognition Therapeutics
CGTX
$82.3M
| $18.2K | ﹤0.01% |
24,000
| – | – |
|
3765
Treace Medical Concepts
TMCI
$259M
| $18K | ﹤0.01% |
13,455
-140
| -1% | -$279 |
|
3766
Beyond Meat
BYND
$288M
| $17.4K | ﹤0.01% |
+24,787
| New | +$19.8K |
|
|
OBAI
3767
Our Bond Inc
OBAI
$11.2M
| $17.2K | ﹤0.01% |
+11,774
| New | +$52.1K |
|
3768
Laser Photonics
LASE
$51.5M
| $16K | ﹤0.01% |
+16,000
| New | +$21.5K |
|
|
CJMB
3769
Callan JMB Inc
CJMB
$14.4M
| $15.6K | ﹤0.01% |
12,500
| – | – |
|
|
DFNS
3770
T3 Defense Inc
DFNS
$4.4M
| $15.3K | ﹤0.01% |
171
-5
| -3% | -$1.35K |
|
3771
Rackspace Technology
RXT
$1B
| $15.1K | ﹤0.01% |
15,367
+5,367
| +54% | +$6.52K |
|
3772
Pacific Biosciences
PACB
$422M
| $14.9K | ﹤0.01% |
11,287
+1,184
| +12% | +$2.12K |
|
3773
Heron Therapeutics
HRTX
$86.3M
| $14.1K | ﹤0.01% |
17,612
+816
| +5% | +$946 |
|
3774
Humacyte
HUMA
$168M
| $14K | ﹤0.01% |
23,085
+4,782
| +26% | +$4.97K |
|
|
MAPS
3775
DELISTED
WM TECHNOLOGY INC A
MAPS
| $13.6K | ﹤0.01% |
20,601
+1,450
| +8% | +$1.06K |
|
Similar funds
HighTower Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, HighTower Advisors held 3,988 positions worth $94.2B, up 3% from $91.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
HighTower Advisors deployed $3.88B of net new capital in Q1 2026, opening 344 new positions and adding to 1,983 existing holdings. Its largest new stake was Invesco Oil & Gas Services ETF: 668,746 shares worth $27.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $129M trimmed.
- HighTower Advisors's largest Q1 2026 buy was Invesco Oil & Gas Services ETF: 668,746 shares worth $27.7M.
- HighTower Advisors added most to Johnson & Johnson in Q1 2026, an estimated $1.52B increase.
- HighTower Advisors's biggest Q1 2026 reduction was ExxonMobil, cutting an estimated $129M.
- HighTower Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $125M.
- HighTower Advisors's ten largest holdings make up 19% of its $94.2B portfolio in Q1 2026.
- HighTower Advisors opened 344 new positions and closed 194 in Q1 2026.
- HighTower Advisors's portfolio value rose 3% quarter-over-quarter to $94.2B.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.